A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology
✍ Scribed by J-P. Cazenave; G. Folléa; L. Bardiaux; J.-M. Boiron; B. Lafeuillade; M. Debost; B. Lioure; J-L. Harousseau; R. Tabrizi; J.-Y. Cahn; M. Michallet; D. Ambruso; R. Schots; J.-D. Tissot; L. Sensebé; T. Kondo; J. McCullough; Paolo Rebulla; Gines Escolar; P. Mintz; N.M. Heddle; R.P. Goodrich; J. Bruhwyler; C. Le; R.J. Cook; B. Stouch; for members of the The Mirasol Clinical Evaluation Study Group
- Book ID
- 109146005
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 344 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background. Platelet‐rich plasma (PRP) and platelet‐poor plasma (PPP) have been used to improve hemostasis and wound healing after surgery; however, randomized controlled trials proving their efficacy are lacking. ## Methods. Hemithyroidectomy was performed on 52 patients. Autolog